Emi Hifumi - Search Results

Year	Number of Results
2002	2
2003	2
2004	5
2005	3
2006	3
2007	2
2008	3
2010	2
2011	2
2012	1
2013	1
2015	2
2016	2
2017	1
2019	1
2020	3
2021	2
2022	2
2023	2
2024	0

1

Role of the constant region domain in the structural diversity of human antibody light chains.

Hifumi E, Taguchi H, Kato R, Uda T. Hifumi E, et al. FASEB J. 2017 Apr;31(4):1668-1677. doi: 10.1096/fj.201600819R. Epub 2017 Jan 17. FASEB J. 2017. PMID: 28096233

2

Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3.

Hifumi E, Taguchi H, Nonaka T, Uda T. Hifumi E, et al. Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(6):155-172. doi: 10.2183/pjab.99.010. Proc Jpn Acad Ser B Phys Biol Sci. 2023. PMID: 37331814 Free PMC article. Review.

3

Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens.

Nonaka T, Taguchi H, Uda T, Hifumi E. Nonaka T, et al. Among authors: hifumi e. Int J Mol Sci. 2022 Nov 18;23(22):14351. doi: 10.3390/ijms232214351. Int J Mol Sci. 2022. PMID: 36430828 Free PMC article.

4

A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain.

Hifumi E, Nonaka T, Taguchi H, Uda T. Hifumi E, et al. Sci Rep. 2022 Nov 10;12(1):19185. doi: 10.1038/s41598-022-23689-6. Sci Rep. 2022. PMID: 36357546 Free PMC article.

5

Modulation of Double Zwitterionic Block Copolymer Aggregates by Zwitterion-Specific Interactions.

Shimizu A, Hifumi E, Kojio K, Takahara A, Higaki Y. Shimizu A, et al. Among authors: hifumi e. Langmuir. 2021 Dec 21;37(50):14760-14766. doi: 10.1021/acs.langmuir.1c02809. Epub 2021 Dec 10. Langmuir. 2021. PMID: 34889092

6

Structural and thermodynamic insights into antibody light chain tetramer formation through 3D domain swapping.

Sakai T, Mashima T, Kobayashi N, Ogata H, Duan L, Fujiki R, Hengphasatporn K, Uda T, Shigeta Y, Hifumi E, Hirota S. Sakai T, et al. Among authors: hifumi e. Nat Commun. 2023 Dec 8;14(1):7807. doi: 10.1038/s41467-023-43443-4. Nat Commun. 2023. PMID: 38065949 Free PMC article.

7

A new algorithm to convert a normal antibody into the corresponding catalytic antibody.

Hifumi E, Taguchi H, Tsuda H, Minagawa T, Nonaka T, Uda T. Hifumi E, et al. Sci Adv. 2020 Mar 25;6(13):eaay6441. doi: 10.1126/sciadv.aay6441. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32232151 Free PMC article.

8

Decomposition of amyloid fibrils by NIR-active upconversion nanoparticles.

Harada T, Matsuzaki H, Oyama R, Takeuchi T, Takei T, Ninomiya T, Takami K, Inoue T, Nishiguchi H, Hifumi E, Shinto H, Takahashi H, Umemura K. Harada T, et al. Among authors: hifumi e. Photochem Photobiol Sci. 2020 Jan 22;19(1):29-33. doi: 10.1039/c9pp00356h. Photochem Photobiol Sci. 2020. PMID: 31932832

9

Super catalytic antibody and antigenase.

Uda T, Hifumi E. Uda T, et al. Among authors: hifumi e. J Biosci Bioeng. 2004;97(3):143-52. doi: 10.1016/S1389-1723(04)70183-8. J Biosci Bioeng. 2004. PMID: 16233607

10

Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 molecule.

Hifumi E, Taguchi H, Nonaka T, Harada T, Uda T. Hifumi E, et al. RSC Chem Biol. 2020 Dec 10;2(1):220-229. doi: 10.1039/d0cb00155d. eCollection 2021 Feb 1. RSC Chem Biol. 2020. PMID: 34458785 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year